CTRI/2022/12/047825
Recruiting
Phase 3
A Randomised Controlled Trial to Compare the Effect of Jalaukavacharana and Virechana with Ichhabhedi Rasa in the Management of Vicharchika with Special Reference to Atopic Eczema
Dr. POOJA PRATAP GIRI0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Sponsor
- Dr. POOJA PRATAP GIRI
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients of age group between 16\-65 years.
- •2\. Lesions not more than 12cm in diameter.
- •3\. Patients having cardinal symptoms like itching, erythema, blackish
- •discoloration, discharge.
- •4\. Patients who are fit for Jalaukavacharana36 and Virechana
Exclusion Criteria
- •1\. Lesions with secondary infection.
- •2\. Patients on corticosteroids treatment.
- •3\. Patients having systemic disorders, any drug reaction and allergic history.
- •4\. Patients having uncontrolled diabetes.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 1
Effect of coconut oil versus petroleum jelly on prevention on diaper rashHealth Condition 1: L22- Diaper dermatitisCTRI/2020/05/025256ational Institute of Nursing Education
Recruiting
Phase 4
Comparison of the Effect of Zoledronic Acid versus a Structured Exercise Programme in OsteoporosisCTRI/2018/03/012837AIIMS New Delhi
Recruiting
Phase 4
Comparison of Effect of Adalimumab versus Hyaluronic Acid in Knee OsteoarthritisHealth Condition 1: null- Primary Osteoarthritis of the KneeCTRI/2018/09/015662All India Institute of Medical Sciences
Completed
Phase 2
Oral carbohydrate intake on labor progressDelivery.Single spontaneous deliveryIRCT201105155805N2Medical Sciences Vice Chancellor for Reasearch, Tehran University of Medical Sciences (TUMS)187
Completed
N/A
A comparison study to understand which is better between injection paracetamol and injection tramadol as anaesthetic agent to reduce pain during deliveryHealth Condition 1: O80- Encounter for full-term uncomplicated deliveryCTRI/2022/07/044230Dr Priyanka Bhuvanendran220